Published in the Commonwealth of Australia Gazette No. GN 49, 14 December 2005
THERAPEUTIC GOODS ACT 1989
THERAPEUTIC GOODS REGULATIONS
I, PIO CESARIN, Director - Non-Prescription Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of Section 42DF(1) of the Therapeutic Goods Act 1989, give notice that the restricted representations described in paragraph (a) below, have been approved for use in advertisements directed to consumers, for the products listed in paragraph (b) subject to the conditions outlined in paragraph (c):
Representations to the effect that advertisements to consumers for the goods described in paragraph (b) may refer to:
"Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life";
medicines entered in the Australian Register of Therapeutic Goods containing vitamin D; and
the advertised medicines may only contain a maximum recommended daily dose of 25 micrograms or less of vitamin D and as a minimum, also contain at least 25% of the RDI in the recommended daily dose of vitamin D for the intended consumers to which advertising is directed.
Dated this 1st day of December 2005
PIO CESARIN Delegate of the Secretary to the Department of Health and Ageing
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.